Mary Thompson (@MaryThompsonMTS) profile picture

Mary Thompson

@MaryThompsonMTS

Executive Editor of The MedTech Strategist (published by Innovation In Medtech), providing market insight and analysis for the medical device industry.

medtechinno.com
Joined August 2014
  • Tweets53
  • Following226
  • Followers149
6Media
Photo by Mary Thompson (@MaryThompsonMTS)Photo by Mary Thompson (@MaryThompsonMTS)Photo by Mary Thompson (@MaryThompsonMTS)Photo by Mary Thompson (@MaryThompsonMTS)Photo by Mary Thompson (@MaryThompsonMTS)Photo by Mary Thompson (@MaryThompsonMTS)
Check out the latest issue of MedTech Strategist for an enlightening (and surprising) survey and discussion of the medtech start-up ecosystem from #deloitteconsulting and #medtechinnovator lnkd.in/e86ktEsp
The Shifting Start-Up Ecosystem: Insights on the Future of Medtech | Mary Thompson

The Shifting Start-Up Ecosystem: Insights on the Future of Medtech | Mary Thompson

Check out the latest issue of MedTech Strategist for an enlightening (and surprising) survey and discussion of the medtech start-up ecosystem from #deloitteconsulting and #medtechinnovator

linkedin.com
Herpes Viruses Implicated in Alzheimer’s Disease the-scientist.com/?articles.…
1
3
FDA has approved Senseonics' Eversense 90-day implantable continuous glucose monitoring system multivu.com/players/English/…
FDA Approves World’s First Long-Term Implantable Continuous Glucose Monitoring System for Marketing...

FDA Approves World’s First Long-Term Implantable Continuous Glucose Monitoring System for Marketing...

Senseonics Holdings, Inc. (NYSE American: SENS) today announced the U.S. Food and Drug Administration has approved its Pre-market Approval (PMA) application to

multivu.com
1
Senseonics and @BetaBionics have announced a partnership to integrate glucose data from Senseonics' Eversense implantable continuous glucose sensor into Beta Bionics' iLet Bionic Pancreas system. (senseonics.com/investor-rela…)
2
4
Senseonics Announces Favorable Outcome of FDA Advisory Committee on the Eversense System | Business Wire businesswire.com/news/home/2…
1
6
JDRF touts win after Anthem decides to cover artificial pancreas systems | Drug Delivery Business sumo.ly/JrFO
3
Dexcom Submits G6 Sensor to the FDA | diaTribe shar.es/1MaMqS
#cybersecurity tops @ECRI_Institute's Health Tech Top 10 Hazards list bit.ly/2zgNmGd. @MedTechStrat takes deep dive in 10-30 issue
Image from Mary Thompson (@MaryThompsonMTS)
1
1
1
FDA OKs ABT's FreeStyle Libre wearable glucose monitor as replacemnt for BGM; will be sold by scrip in retail pharms (more @MedTechStrat )
1
No More Absorb BVS: Abbott Puts a Stop to Sales tctmd.com/news/no-more-absor…
No More Absorb BVS: Abbott Puts a Stop to Sales

No More Absorb BVS: Abbott Puts a Stop to Sales

The company announced its intention to stop selling the bioresorbable scaffold in all countries but said follow-up of existing studies will continue.

tctmd.com
Looking forward to this teapaw.org/BrennanSpiegel/status/…
Brennan Spiegel, MD, MSHS (@BrennanSpiegel) profile pictureBrennan Spiegel, MD, MSHS@BrennanSpiegel21 Aug 2017
Do #wearables significantly improve pt outcomes? We'll publish on this soon in Digital Med, new @EricTopol journal. Quick ans: not quite yet
Image from Brennan Spiegel, MD, MSHS (@BrennanSpiegel)
Women Physicians Who Changed the Course of American Medicine medscape.com/features/slides…
1
Replying to @KFF
@KaiserFamFound media briefing today: ACA repeal could have wide reaching implications for women's health
CMS OKs Medicare coverage for Dexcom G5 CGM--a major milestone for diabetes pts. See our 8/24/16 q&a w/Dexcom CEO Kevin Sayer @MedTechStrat
Image from Mary Thompson (@MaryThompsonMTS)
1
2
FDA has approved Dexcom's G5 CGM as replacement for finger sticks (see our q&a w/CEO Kevin Sayer 8/24/16 issue of MTS) #themedtechstrategist
2
1
Israel's GI View has FDA OK for disposable Aer-O-Scope colonoscope w/working channels. US launch in 2017 (more in @MedTechStrat Vol 2 No 3)
Image from Mary Thompson (@MaryThompsonMTS)
Companion Medical Receives FDA Clearance for Smart Insulin Delivery System prn.to/2axux78
FDA panel voted 8 to 2 today that benefits outweigh risks for use of Dexcom G5 CGM data to make insulin dosing decisons
1
#LifeBond gets IDE study approval; working to bring colon surgery sealant to US mkt (more on LifeBond in #TheMedTechStrategist Vol.1/No.5)
US hospitals prepare to expand into lower-risk TAVR patients: TAVR market update in the next issue of @MedTechStrat teapaw.org/ShelleyWood2/status/72…
Shelley Wood (she/her) (@ShelleyWood2) profile pictureShelley Wood (she/her)@ShelleyWood227 Apr 2016
Selected TAVR patients can skip the ICU, but pacemaker needs may thwart streamlining. tctmd.com/show.aspx?id=13495…
1
1

No more items